BCMab-1

N/A

Report date: 2025/03/18 18:11:21

Base Information

Drug NameBCMab-1
Drug Alias Namemonoclonal antibody (Beijing National Technology Transfer Center of CAS)monoclonal antibody (Technical Institute of Physics and Chemistry)monoclonal antibody (Chinese Academy of Sciences)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionIntegrin alpha 3/beta 1 modulators
TargetsIntegrin alpha 3/beta 1
Therapy Area/IndicationsUrinary Bladder Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesTechnical Institute Of Physics And Chemistry, Chinese Academy Of Sciences
China Registration ClassN/A

Develop Information

Active CompaniesTechnical Institute Of Physics And Chemistry, Chinese Academy Of Sciences
Inactive CompaniesN/A
Active IndicationsUrinary Bladder Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A